Atossa Therapeutics Statistics

Total Valuation

FRA:YAG has a market cap or net worth of EUR 30.77 million. The enterprise value is -13.23 million.

Market Cap	30.77M
Enterprise Value	-13.23M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	8.61M
Shares Outstanding	n/a
Shares Change (YoY)	+2.39%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.73
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.51
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.59

Financial Position

The company has a current ratio of 6.77

Current Ratio	6.77
Quick Ratio	6.30
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.89% and return on invested capital (ROIC) is -33.26%.

Return on Equity (ROE)	-48.89%
Return on Assets (ROA)	-29.87%
Return on Invested Capital (ROIC)	-33.26%
Return on Capital Employed (ROCE)	-65.99%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-1.71M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-45.59%
50-Day Moving Average	9.01
200-Day Moving Average	10.45
Relative Strength Index (RSI)	38.11
Average Volume (20 Days)	404

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-28.00M
Pretax Income	-25.72M
Net Income	-25.72M
EBITDA	-27.99M
EBIT	-28.00M
Earnings Per Share (EPS)	-3.00

Full Income Statement

Balance Sheet

The company has 44.19 million in cash and n/a in debt, with a net cash position of 44.19 million.

Cash & Cash Equivalents	44.19M
Total Debt	n/a
Net Cash	44.19M
Net Cash Per Share	n/a
Equity (Book Value)	42.43M
Book Value Per Share	4.93
Working Capital	40.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -22.39 million and capital expenditures -13,637, giving a free cash flow of -22.41 million.

Operating Cash Flow	-22.39M
Capital Expenditures	-13,637
Free Cash Flow	-22.41M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:YAG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.39%
Shareholder Yield	-2.39%
Earnings Yield	-83.59%
FCF Yield	-72.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 20, 2018. It was a reverse split with a ratio of 0.0833333333.

Last Split Date	Apr 20, 2018
Split Type	Reverse
Split Ratio	0.0833333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	1